Investor Relations

By helping our clients to consistently outperform and build a strong foundation for the future, Cowen aims to deliver long-term value for our shareholders.

FINANCIALS

Explore our SEC filings, corporate governance information and other shareholder information. Take a moment to read our latest Annual Report.

Stay up to date

GET IN TOUCH

Cowen Investor inquiries will be routed to J.T. Farley, Managing Director and Head of Investor Relations.

Stock Quote

COWN

Exchange NASDAQ (USD)
Price $34.70
Change +0 / +0.00%
Volume 0

Data as of 09/16/2021 4:00 PM UTC.
Minimum 15 minute delay.

News

Lycia Therapeutics Announces $70 Million Series B Financing Led by Redmile Group with Participation from Founding Investor Versant Ventures

Read the article “Lycia Therapeutics Announces $70 Million Series B Financing Led by Redmile Group with Participation from Founding Investor Versant Ventures”
News

Obsidian Therapeutics Announces Closing of $115 Million Series B Financing

Read the article “Obsidian Therapeutics Announces Closing of $115 Million Series B Financing”
News

John Patrick Miller Joins Cowen Research’s Washington Research Group to Cover ESG and Sustainability Policy

Read the article “John Patrick Miller Joins Cowen Research’s Washington Research Group to Cover ESG and Sustainability Policy”